NCT01148342View on ClinicalTrials.gov

Neurobiology and Pharmacokinets of Acute MDMA Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

February 10, 2004

Study Completion Date

July 18, 2012

Conditions
Substance-Related Disorders
Interventions
DRUG

MDMA

DRUG

(+/-)3,4-methylenedioxymethamphetamine Hydrochloride, MDMA HCI Capsules

0, 1.0 \& 1.6 mg/kg

Trial Locations (1)

21224

National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT01148342 - Neurobiology and Pharmacokinets of Acute MDMA Administration | Biotech Hunter | Biotech Hunter